Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Arcus Biosciences Inc. (RCUS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 1,882,722 $46,579 +4781% 2.87%
2.
EcoR1 Capital

Oleg Nodelman

1,810,000 $44,779 +520% 3.3%
3.
Partner Fund Management

Christopher Medlock James

1,735,581 $42,938 +115% 2.22%
4.
Farallon Capital

Thomas Steyer

1,000,000 $24,740 0.2%
5.
Alkeon Capital Management

Panayotis Takis Sparaggis

614,845 $15,211 +413% 0.03%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$21.57 5,000 Officer 5,000 2020-09-09 Filing
$23.38 32,050 Officer, Director 3,231,179 2020-08-10 Filing
$21.44 11,655 Officer, Director 3,199,129 2020-08-07 Filing
$19.68 100 Officer 600 2020-07-31 Filing
$19.77 100 Officer 500 2020-07-31 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 30,815 $762,363 0%
2. 5,408 $134,000 0.04%
3. 3,453 $85,427 0%
4. 2,705,575 $66,936 0%
5. 2,639,092 $65,292 0%
News See All